𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High dose folinic acid and 5-fluorouracil bolus and continuous infusion for patients with advanced colorectal cancer

✍ Scribed by Yves H. Bécouarn; René C. Brunet; Marie-Laurence P. Rouhier; Emmanuel J. Bussières; Antoine R. Avril; Pierre M. Richaud; Jean-Marie A. Dilhuydy

Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
530 KB
Volume
76
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized phase III Study of 5-fluorour
Randomized phase III Study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer
✍ Dennie V. Jones; Roger J. Winn; Barry W. Brown; Lawrence B. Levy; Reginald P. Pu 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

Background. Metastatic colorectal cancer is generally incurable. The most active regimen available, 5-fluorouracil(5-FU) and folinic acid (Leucovorin), produces response rates of approximately 25% to 30%. Methyl-lomustine is a nitrosourea with modest activity against colorectal cancer. A randomized

Continuous systemic 5-fluorouracil infus
Continuous systemic 5-fluorouracil infusion in advanced colorectal cancer: Results in 91 patients
✍ R. Hansen; E. Quebbeman; R. Ausman; J. Frick; P. Ritch; W. Schulte; C. Haas; P. 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB

Ninety-one patients with metastatic colorectal cancer were treated with continuous ambulatory 5-fluorouracil(5FU) infusion 250-300 mg/m2/day through a chronic indwelling central venous catheter. Twenty-six of the 91 patients (29%) had received previous bolus 5FU. Fifty-eight of the 91 patients (64%)

A phase II trial of weekly high dose con
A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer
✍ Enrique Aranda; Andrés Cervantes; Javier Dorta; Esperanza Blanco; Carlos Fernánd 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer